Characteristics, Properties and Analytical Methods for Determination of Dropropizine and Levodropropizine: A Review

References

• De Blasio, F.; Dicpinigaitis, P. V.; De Danieli, G.; Lanata, L.; Zanasi, A. Efficacy of Levodropropizine in Pediatric Cough. Pulm. Pharmacol. Ther. 2012, 25, 337–342. DOI: 10.1016/j.pupt.2012.05.010.
   PubMed Web of Science ®Google Scholar
• Zanasi, A.; Lanata, L.; Fontana, G.; Saibene, F.; Dicpinigaitis, P.; De Blasio, F. Levodropropizine for Treating Cough in Adult and Children: A Meta-Analysis of Published Studies. Multidiscip. Resp. Med. 2015, 10, 10–19.
   PubMed Web of Science ®Google Scholar
• Dicpinigaitis, P. V. Current and Future Peripherally-Acting Antitussives. Respir. Physiol. Neuro. 2006, 152, 356–362. DOI: 10.1016/j.resp.2005.11.010.
   PubMed Web of Science ®Google Scholar
• Irwin, R. S.; Curley, F. J.; Bennett, F. M. Appropriate Use of Antitussives and Protussives. A Practical Review. Drugs 1993, 46, 80–91. DOI: 10.2165/00003495-199346010-00006.
   PubMed Web of Science ®Google Scholar
• Dicpinigaitis, P. V.; Morice, A. H.; Birring, S. S.; McGarvey, L.; Smith, J. A.; Canning, B. J.; Page, C. P. Antitussive Drugs–Past, Present, and Future. Pharmacol. Rev. 2014, 66, 1–44.
   PubMed Web of Science ®Google Scholar
• De Blasio, F.; Virchow, J. C.; Polverino, M.; Zanasi, A.; Behrakis, P. K.; Kilinç, G.; Balsamo, R.; De Danieli, G.; Lanata, L. Cough Management: A Practical Approach. Cough 2011, 7, 7–12. DOI: 10.1186/1745-9974-7-7.
   PubMedGoogle Scholar
• Lavezzo, A.; Melillo, G.; Clavenna, G.; Omini, C. Peripheral Site of Action of Levodropropizine in Experimentally-Induced Cough: Role of Sensory Neuropeptides. Pulm. Pharmacol. 1992, 5, 143–147. DOI: 10.1016/0952-0600(92)90033-D.
   PubMedGoogle Scholar
• Fischer, J.; Andrès, E.; Stein, R. Revue Pharmacologique des Antitussifs et leur Place Dans le Traitement de la Bronchite Aiguë Virale. Méd. Thérapeut. 2017, 23, 14–20.
   Google Scholar
• National Health Surveillance Agency. Resolution RDC n°17, of April 16, 2010. Provides on Good Practices of Drug Manufacture. Official Journal of the Union, Brasília, DF, April 19, 2010.
   Google Scholar
• Rozet, E.; Ceccato, A.; Hubert, C.; Ziemons, E.; Oprean, R.; Rudaz, S.; Boulanger, B.; Hubert, P. Analysis of Recent Pharmaceutical Regulatory Documents on Analytical Method Validation. J. Chromatogr. A 2007, 1158, 111–125. DOI: 10.1016/j.chroma.2007.03.111.
   PubMed Web of Science ®Google Scholar
• Morren, H. Substituted Phenyl-Piperazine Compounds. U.S. Patent 3,163,649, December 29, 1964.
   Google Scholar
• Drug Bank. Drug & Drug Target Database. https://www.drugbank.ca/drugs/DB12472 (accessed May 16, 2018).
   Google Scholar
• EP. European Pharmacopoeia, 8th ed.; Council of Europe: Strasbourg, 2013.
   Google Scholar
• Borsa, M.; Tonon, G.; Malandrino, S. Optically Active Compounds with Antitussive and Central Sedative Activity, a Process for the Preparation thereof and Compositions Containing the Same. Eur. Patent 147,847, July 10, 1985.
   Google Scholar
• Shum, W. P.; Chen, J. Synthesis and Structural Characterization of Enantiopure Levodropropizine. Chirality 1996, 8, 6–10. DOI: 10.1002/(SICI)1520-636X(1996)8:1<6::AID-CHIR3>3.0.CO;2-J.
   Web of Science ®Google Scholar
• Malandrino, S.; Melillo, G.; Bestetti, A.; Borsa, M.; Giuliani, P.; Tonon, G. C. Antitussive Properties of Levodropropizine. Arzneim. Forsch. 1988, 38, 1141–1143.
   PubMed Web of Science ®Google Scholar
• Van Iersel, J. T. M.; Elferink, V. H. M. Preparation of Enantiomers of Dropropizine by Coupling of 1-phenylpiperazine with Optically Active Glycidol. Eur. Patent 349,066, January 3, 1990.
   Google Scholar
• Giani, R. A Process for the Optical Resolution of Dropropizine. Eur. Patent 409,044, January 23, 1991.
   Google Scholar
• Giani, R.; Marinone, E.; MePo, G.; Borsa, M.; Tonon, G. C. Synthesis and Pharmacological Screening of New Phenyl Piperazine Propane Derivatives and Their Enantiomers. Arzneim. Forsch. 1988, 38, 1139–1141.
   PubMed Web of Science ®Google Scholar
• Paradisi, G.; Bombarda, C.; Polacci, A. C. A Condensation Process for the Preparation of the Enantiomers of Dropropizine. Eur. Patent 575,776, December 29, 1993.
   Google Scholar
• Bianchi, D.; Bosetti, A.; Cesti, P.; Golini, P. Enzymatic Resolution of 1.2-Diols: Preparation of Optically Pure Dropropizine. Tetrahedron. Lett. 1992, 33, 3231–3234. DOI: 10.1016/S0040-4039(00)79859-5.
   Web of Science ®Google Scholar
• Salunkhe, M. M.; Nair, R. V. Novel Route for the Resolution of Both Enantiomers of Dropropizine by Using Oxime Esters and Supported Lipases of Pseudomonas cepacia. Enzyme Microb. Technol. 2001, 28, 333–338. DOI: 10.1016/S0141-0229(00)00347-1.
   PubMed Web of Science ®Google Scholar
• Caselli, E.; Tosi, G.; Forni, A.; Bucciarelli, M.; Prati, F. Chemo-Enzymatic Synthesis of Levodropropizine. Farmaco. Prat. 2003, 58, 1029–1032. DOI: 10.1016/S0014-827X(03)00189-7.
   Google Scholar
• ACD/Labs, I-Lab 2.0. Advanced Chemistry Developenent, Inc, Toronto. ON, Canadá. http://www.acdlabs.com/resources/ilab/ (accessed May 18, 2018).
   Google Scholar
• Pubchem. Pubchem Compound Database. https://pubchem.ncbi.nlm.nih.gov/compound/3169 (accessed May 16, 2018).
   Google Scholar
• Narin, I.; Sarioglan, S.; Anilanmert, B.; Sari, H. pKa Determinations for Montelukast Sodium and Levodropropizine. J. Solution Chem. 2010, 39, 1582–1588. DOI: 10.1007/s10953-010-9604-z.
   Web of Science ®Google Scholar
• Shams, H.; Daffonchio, L.; Scheid, P. Effects of Levodropropizine on Vagal Afferent C-Fibres in the Cat. Br. J. Pharmacol. 1996, 117, 853–858. DOI: 10.1111/j.1476-5381.1996.tb15271.x.
   PubMed Web of Science ®Google Scholar
• Melillo, G.; Malandrino, S.; Rossoni, G.; Caselli, G.; Bestetti, A.; Borsa, M.; Tonon, G. C.; Berti, F. General Pharmacology of the New Antitussive Levodropropizine. Arzneim. Forsch. 1988, 38, 1144–1150.
   PubMed Web of Science ®Google Scholar
• Zanasi, A.; Lanata, L.; Fontana, G.; Saibene, F.; Dicpinigaitis, P.; De Blasio, F. Levodropropizine for Treating Cough in Adult and Children: A Meta-Analysis of Published Studies. Multidiscip. Respir. Med. 2015, 31, 1–6.
   Google Scholar
• Gou, Z. P.; Zheng, L.; Wang, Y.; Feng, P.; Xiang, J. Single- and Multiple-Dose Pharmacokinetics of the Peripheral Non-Narcotic Antitussive Moguisteine in Healthy Chinese Volunteers. Eur. J. Pharm. Sci. 2019, 130, 166–172. DOI: 10.1016/j.ejps.2019.01.029.
   PubMed Web of Science ®Google Scholar
• Borsa, M.; Glavenna, G.; Ferrari, M. P.; Canali, S.; Giachetti, C.; Zanolo, G. Linearity of Levodropropizine, a New Antitussive Drug, in the Healthy Volunteer. Eur. J. Drug Metab. Pharmacokinet. 1991, 16, 178–184.
   Google Scholar
• Zaratin, P.; De Angelis, L.; Cattabeni, F. Gas Chromatographic-Mass Spectrometric Determination of Levodropropizine Plasma Levels in Healthy Volunteers. Arzneim. Forsch. 1988, 38, 1156–1158.
   PubMed Web of Science ®Google Scholar
• Tang, Y.; Zhao, L.; Wang, Y.; Fawcett, J. P.; Gu, J. Rapid and Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantitation of Levodropropizine in Human Plasma. J. Chromatogr. B 2005, 819, 185–189. DOI: 10.1016/j.jchromb.2005.01.029.
   PubMed Web of Science ®Google Scholar
• Lee, S.; Nam, K. Y.; Oh, J.; Lee, S.; Cho, S. M.; Choi, Y. W.; Cho, J. Y.; Lee, B. J.; Hong, J. H. Evaluation of the Effects of Food on Levodropropizine Controlled-Release Tablet and Its Pharmacokinetic Profile in Comparison to That of Immediate-Release Tablet. Drug Des. Devel. Ther. 2018, 23, 1413–1420. DOI: 10.2147/DDDT.S146958.
   Google Scholar
• Jang, J. W.; Seo, J. H.; Jo, M. H.; Lee, Y. J.; Cho, Y. W.; Yim, S. V.; Lee, K. T. Relative Bioavailability of Levodropropizine 60 mg Capsule and Syrup Formulations in Healthy Male Korean Volunteers: A Single Dose, Randomized-Sequence, Open-Label, Two-Way Crossover Study. Int. J. Clin. Pharmacol. Ther. 2013, 51, 152–160. DOI: 10.5414/CP201730.
   PubMed Web of Science ®Google Scholar
• Gabani, B. B.; Todmal, U.; Saini, N. K.; Balakrishna, V. A.; Sulochana, S. P.; Mohd, Z.; Narayan, B.; Praharaj, S.; Nuggehally, R. S.; Mullangi, R. Stereoselective Pharmacokinetics and Tissue Distribution of Levodropropizine after Administration of Pure Levodropropizine and the Rac-Dropropizine to Sprague Dawley Rats. Xenobiotica 2019, 21, 1–10. DOI: 10.1080/00498254.2019.1599148.
   Google Scholar
• Staack, R. F.; Theobald, D. S.; Maurer, H. H. Studies on the Human Metabolism and the Toxicologic Detection of the Cough Suppressant Dropropizine in Urine Using Gas Chromatography-Mass Spectrometry. Ther. Drug Monit. 2004, 26, 441–449. DOI: 10.1097/00007691-200408000-00015.
   PubMed Web of Science ®Google Scholar
• Bestetti, A.; Giuliani, P.; Nunziata, A.; Melillo, G.; Tonon, G. C. Safety and Toxicological Profile of the New Antitussive Levodropropizine. Arzneim. Forsch. 1988, 38, 1150–1155.
   PubMed Web of Science ®Google Scholar
• Siddiqui, M. R.; AlOthman, Z. A.; Rahman, N. Analytical Techniques in Pharmaceutical Analysis: A Review. Arab. J. Chem. 2017, 10, S1409–S1421. DOI: 10.1016/j.arabjc.2013.04.016.
   Web of Science ®Google Scholar
• Consortti, L. P.; Salgado, H. R. N. A Critical Review of Analytical Methods for Quantification of Cefotaxime. Crit. Rev. Anal. Chem. 2017, 47, 359–371. DOI: 10.1080/10408347.2017.1298988.
   PubMed Web of Science ®Google Scholar
• Ermer, J.; Miller, J. H. M. Method Validation in Pharmaceutical Analysis. A Guide to Best Practice; Wiley-VCH: Weinheim, 2005.
   Google Scholar
• National Health Surveillance Agency. Resolution RDC n°. 166 of July 24, 2017. Provides for Validation of Analytical Methods and other Measures. Official Journal of the Union, Brasília, DF, July 25, 2017.
   Google Scholar
• Agin, F.; Karadas, N.; Uslu, B.; Ozkan, S. A. Electroanalytical Characterization of Levodropropizine and Its Voltammetric Determination in Pharmaceuticals. Curr Pharmaceut Anal. 2013, 9, 299–309. DOI: 10.2174/1573412911309030008.
   Web of Science ®Google Scholar
• Zayed, S. I. M.; Arida, H. A. M. Voltammetric Determination of the Cough Suppressant Drug Dropropizine in Its Pharmaceutical Formulations and Human Urine. Int. J. Electrochem. Sci. 2015, 10, 3250–3259.
   Web of Science ®Google Scholar
• Abdallah, O. M. Sensitive Spectrophotometric Method for Quantitation of Guaifenesin and Dropropizine in Their Dosage Forms. Int. J. Anal. Chem. 2010, 2010, 1–5. DOI: 10.1155/2010/704564.
   Google Scholar
• Yousfan, A.; Hasian, J. Preparation and Evaluation of Levodropropizine Suppositories. J. Chem. Pharm. Res. 2015, 7, 274–282.
   Google Scholar
• Elwy, H. M.; Abdel-Moaty, M. M.; Abdel-Hamid, S. M. Conductometric Determination of Dropropizine and Tizanidine Hydrochloride in Their Pharmaceutical Formulations. Anal. Bioanal. Electrochem. 2015, 7, 105–117.
   Google Scholar
• Brazilian Health Surveillance Agency. Brazilian Pharmacopoeia, 5th ed.; São Paulo: Atheneu, 2010.
   Google Scholar
• USP. United States Pharmacopeia, 40th ed.; United States Convention: Rockville, 2017.
   Google Scholar
• Patil, S. H.; Janjale, M. V. Novel and Validated Titrimetric Method for Determination of Selected Angiotensin-II-Receptor Antagonists in Pharmaceutical Preparations and Its Comparison with UV Spectrophotometric Determination. J. Pharm. Anal. 2012, 2, 470–477. DOI: 10.1016/j.jpha.2012.03.009.
   PubMedGoogle Scholar
• Elqudaby, H. M.; Mohamed, G. G.; Ali, F. A.; Eid, S. M. Validated Voltammetric Method for the Determination of Some Antiprotozoa Drugs Based on the Reduction at an Activated Glassy Carbon Electrode. Arab. J. Chem. 2013, 6, 327–333. DOI: 10.1016/j.arabjc.2011.05.019.
   Web of Science ®Google Scholar
• Salamanca-Neto, C. A. R.; Eisele, A. P. P.; Resta, V. G.; Scremin, J.; Sartori, E. R. Differential Pulse Voltammetric Method for the Individual and Simultaneous Determination of Antihypertensive Drug Metoprolol and Its Association with Hydrochlorothiazide in Pharmaceutical Dosage Forms. Sens. Actuator. B Chem. 2016, 230, 630–638. DOI: 10.1016/j.snb.2016.02.071.
   Web of Science ®Google Scholar
• Vieira, D. C. M.; Salgado, H. R. N. Comparison of HPLC and UV Spectrophotometric Methods for the Determination of Cefuroxime Sodium in Pharmaceutical Products. J. Chromatogr. Sci. 2011, 49, 508–511. DOI: 10.1093/chrsci/49.7.508.
   PubMed Web of Science ®Google Scholar
• Lee, M. K.; Ahn, Y. M.; Lee, K. R.; Jung, J. H.; Jung, O. S.; Hong, J. Development of a Validated Liquid Chromatographic Method for the Quality Control of Prunellae spica: Determination of Triterpenic Acids. Anal. Chim. Acta 2009, 633, 271–277. DOI: 10.1016/j.aca.2008.12.038.
   PubMed Web of Science ®Google Scholar
• Kumar, P. A.; Raju, T. V. R.; Thirupathi, D.; Kumar, R.; Shree, J. Development and Validation of a Stability-Indicating LC-Method for the Simultaneous Estimation of Levodropropizine, Chloropheniramine, Methylparaben, Propylparaben, and Levodropropizine Impurities. Sci. Phar. 2012, 81, 39–150.
   Google Scholar
• Patil, S. D.; Aher, P.; Ahire, R.; Kshirsagar, S. Development and Validation of Stability Indicating RP-HPLC Method for Levodropropizin. Int. J. Inst. Pharm. Life Sci. 2017, 7, 197–211.
   Google Scholar
• Marco, B. A.; Salgado, H. R. N. Development and Validation of a Green RP-HPLC Method for Quantification of Cefadroxil Capsules. World J. Pharm. Pharm. Sci. 2017, 6, 2074–2091. DOI: 10.20959/wjpps20178-9875.
   Google Scholar
• Weshahy, S. A.; EL-F.; Yaaqob, M. S.; Morcos, M. N.; Hassan, D. W.; Youssef, N. F. Simultaneous Determination of Levodropropizine, Methylparaben, and Propylparaben in Oral Co-Formulated Syrup by RP-HPLC Method. J. Chil. Chem. Soc. 2015, 60, 2729–2733. DOI: 10.4067/S0717-97072015000400018.
   Web of Science ®Google Scholar
• Yan, L.; Li, T.; Zhang, R.; Xu, X.; Zheng, P. HPLC Determination and Steady-State Bio Availability Study of Levodropropizine Sustained-Release Tablets in Dogs. Arch. Pharm. Res. 2006, 29, 514–519. DOI: 10.1007/BF02969426.
   PubMed Web of Science ®Google Scholar
• Gutiérrez, X. P.; Espinosa, V. M. Determinación de Levodropropizina en Gotas Orales por Cromatografía Líquida de Alta Resolución. Rev. Cubana Farm. 2002, 36, 152–156.
   Google Scholar
• Tagliaro, F.; Moffa, M.; De Battisti, Z.; Smith, F. P.; Gentile, M. High-Performance Liquid Chromatographic Determination of Levodropropizine in Human Plasma with Fluorometric Detection. J. Chromatogr. B Biomed. Life Sci. 1996, 685, 165–170. DOI: 10.1016/0378-4347(96)00163-6.
   PubMed Web of Science ®Google Scholar
• Toomula, N.; Kumar, A.; Kumar, S. D.; Bheemidi, V. S. Development and Validation of Analytical Methods for Pharmaceuticals. J. Anal. Bioanal. Tech. 2011, 2, 1–4.
   Google Scholar
• Chandrasekharan, K.; Kannappan, V. Fast Chiral HPLC Procedure for the Simultaneous Determination of Dropropizine Enantiomers and Its Nonpolar Impurity in Raw Material and Pharmaceutical Formulation. Int. J. Pharm. Pharm. Sci. 2014, 6, 103–106.
   Google Scholar
• Balaji, N.; Gabani, B. B.; Todmal, U.; Sulochana, S. P.; Saini, N. K.; Chandran, R.; Mullangi, R. Enantioselective LC‐ESI‐MS/MS Determination of Dropropizine Enantiomers in Rat Plasma and Application to a Pharmacokinetic Study. Biomed. Chromatogr. [Online early access] DOI: 10.1002/bmc.4434.
   Web of Science ®Google Scholar